Arbutus Biopharma Corp Quarterly Liabilities in CAD from Q4 2010 to Q4 2013

Taxonomy & unit: us-gaap: CAD and USD
Description: Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary: Arbutus Biopharma Corp quarterly Liabilities history and growth rate from Q4 2010 to Q4 2013.
Arbutus Biopharma Corp Liabilities for the quarter ending December 31, 2013 was CA$12.5M, a 7.25% increase year-over-year.

Liabilities, Quarterly (CAD)

Liabilities, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2013	12.5M	+846K	+7.25%	Dec 31, 2013	10-K	2014-03-28
Q4 2012	11.7M	+3M	+34.6%	Dec 31, 2012	10-K	2014-03-28
Q4 2011	8.68M	-1.61M	-15.7%	Dec 31, 2011	20-F	2013-03-27
Q4 2010	10.3M			Dec 31, 2010	20-F	2012-03-27

* An asterisk sign (*) next to the value indicates that the value is likely invalid.